11/20/2009

Advanced Cell Technology submitted an investigational new-drug application to conduct an early-stage trial of a stem cell therapy for Stargardt's macular dystrophy, a cause of juvenile blindness. The technique centers on retinal cells developed from human embryonic stem cells.

Related Summaries